Springer, European Journal of Nuclear Medicine and Molecular Imaging, 1(41), p. 21-31, 2013
DOI: 10.1007/s00259-013-2528-2
Full text: Download
The aim of this study was to evaluate the predictive role of pre-therapy fluorodeoxyglucose (FDG) uptake parameters of primary tumour in head and neck cancer (HNC) patients undergoing intensity-modulated radiotherapy (IMRT) with simultaneous integrated boost (SIB) on FDG-positive volume-positron emission tomography (PET) gross tumour volume (PET-GTV).